These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 26621860)

  • 1. Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver.
    Rau M; Schilling AK; Meertens J; Hering I; Weiss J; Jurowich C; Kudlich T; Hermanns HM; Bantel H; Beyersdorf N; Geier A
    J Immunol; 2016 Jan; 196(1):97-105. PubMed ID: 26621860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive diagnostic criteria for nonalcoholic steatohepatitis based on gene expression levels in peripheral blood mononuclear cells.
    Kado A; Tsutsumi T; Enooku K; Fujinaga H; Ikeuchi K; Okushin K; Moriya K; Yotsuyanagi H; Koike K
    J Gastroenterol; 2019 Aug; 54(8):730-741. PubMed ID: 30830270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3, 3'-Diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg/Th17 cells to Treg dominance.
    Liu Y; She W; Wang F; Li J; Wang J; Jiang W
    Int Immunopharmacol; 2014 Dec; 23(2):489-98. PubMed ID: 25281898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease.
    Mao JW; Tang HY; Zhao T; Tan XY; Bi J; Wang BY; Wang YD
    Int J Clin Exp Pathol; 2015; 8(4):3648-58. PubMed ID: 26097546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo.
    Zhen Y; Yao L; Zhong S; Song Y; Cui Y; Li S
    Arch Dermatol Res; 2016 Dec; 308(10):703-710. PubMed ID: 27687555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
    Tang Y; Bian Z; Zhao L; Liu Y; Liang S; Wang Q; Han X; Peng Y; Chen X; Shen L; Qiu D; Li Z; Ma X
    Clin Exp Immunol; 2011 Nov; 166(2):281-90. PubMed ID: 21985374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic Fatty Liver Disease vs. Nonalcoholic Steatohepatitis: Pathological and Clinical Implications.
    Boutari C; Lefkos P; Athyros VG; Karagiannis A; Tziomalos K
    Curr Vasc Pharmacol; 2018; 16(3):214-218. PubMed ID: 28676025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease.
    Wada N; Takaki A; Ikeda F; Yasunaka T; Onji M; Nouso K; Nakatsuka A; Wada J; Koike K; Miyahara K; Shiraha H; Yamamoto K; Okada H
    Hepatol Int; 2017 Jan; 11(1):115-124. PubMed ID: 27826704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of Nonalcoholic Steatohepatitis.
    Machado MV; Diehl AM
    Gastroenterology; 2016 Jun; 150(8):1769-77. PubMed ID: 26928243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lipidomic analysis of nonalcoholic fatty liver disease.
    Puri P; Baillie RA; Wiest MM; Mirshahi F; Choudhury J; Cheung O; Sargeant C; Contos MJ; Sanyal AJ
    Hepatology; 2007 Oct; 46(4):1081-90. PubMed ID: 17654743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver.
    Wang ZH; Zheng KI; Wang XD; Qiao J; Li YY; Zhang L; Zheng MH; Wu J
    Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):452-459. PubMed ID: 34256994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice.
    Rolla S; Alchera E; Imarisio C; Bardina V; Valente G; Cappello P; Mombello C; Follenzi A; Novelli F; Carini R
    Clin Sci (Lond); 2016 Feb; 130(3):193-203. PubMed ID: 26558403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXP3-marked IL-17a-producing regulatory T cells are increased in patients with allergic rhinitis.
    Cheng X; Lou W; Wang C; Zhang W; Han D; Zhang L
    Acta Otolaryngol; 2012 Dec; 132(12):1311-7. PubMed ID: 22992221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver.
    Jamwal R; de la Monte SM; Ogasawara K; Adusumalli S; Barlock BB; Akhlaghi F
    Mol Pharm; 2018 Jul; 15(7):2621-2632. PubMed ID: 29792708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis.
    Chackelevicius CM; Gambaro SE; Tiribelli C; Rosso N
    World J Gastroenterol; 2016 Nov; 22(41):9096-9103. PubMed ID: 27895397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice.
    He B; Wu L; Xie W; Shao Y; Jiang J; Zhao Z; Yan M; Chen Z; Cui D
    BMC Immunol; 2017 Jun; 18(1):33. PubMed ID: 28646856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma.
    Shi YH; Shi GC; Wan HY; Jiang LH; Ai XY; Zhu HX; Tang W; Ma JY; Jin XY; Zhang BY
    Chin Med J (Engl); 2011 Jul; 124(13):1951-6. PubMed ID: 22088452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.